Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 17 (RPS2P17) is a non-functional, processed pseudogene related to the RPS2 gene, which encodes the ribosomal protein S2 found in the 40S subunit of ribosomes[1][5]. Unlike functional ribosomal protein genes, pseudogenes such as RPS2P17 do not encode proteins and lack canonical biological or disease roles. Such pseudogenes are common in the human genome as remnants of gene duplication or retrotransposition events. RPS2P17 should not be considered a therapeutic target or biological entity with druggable properties. Key points: - RPS2P17 is not a functional receptor, enzyme, or transporter, but rather a processed pseudogene. - It has no known therapeutic, drug, or biomarker roles. - The inclusion of RPS2P17 as a drug target is incorrect; if you meant the active ribosomal protein, use "ribosomal protein S2 (RPS2)"[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein S2 pseudogene 17 (RPS2P17).